PT791355E - Metodo para diminuir os daos associados com a isquemia nos tecidos - Google Patents
Metodo para diminuir os daos associados com a isquemia nos tecidosInfo
- Publication number
- PT791355E PT791355E PT97200415T PT97200415T PT791355E PT 791355 E PT791355 E PT 791355E PT 97200415 T PT97200415 T PT 97200415T PT 97200415 T PT97200415 T PT 97200415T PT 791355 E PT791355 E PT 791355E
- Authority
- PT
- Portugal
- Prior art keywords
- ischemia
- daos
- tissues
- decreasing
- mammal
- Prior art date
Links
- 208000028867 ischemia Diseases 0.000 title abstract 2
- 230000003247 decreasing effect Effects 0.000 title 1
- HDARHUHTZKLJET-UHFFFAOYSA-M sodium;3-(n-ethyl-3,5-dimethoxyanilino)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC(OC)=CC(OC)=C1 HDARHUHTZKLJET-UHFFFAOYSA-M 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 229940123659 Sorbitol dehydrogenase inhibitor Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000000451 tissue damage Effects 0.000 abstract 1
- 231100000827 tissue damage Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1270896P | 1996-02-29 | 1996-02-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT791355E true PT791355E (pt) | 2002-08-30 |
Family
ID=21756305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97200415T PT791355E (pt) | 1996-02-29 | 1997-02-13 | Metodo para diminuir os daos associados com a isquemia nos tecidos |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5932581A (pt) |
| EP (1) | EP0791355B1 (pt) |
| JP (1) | JPH09316004A (pt) |
| KR (1) | KR100219972B1 (pt) |
| CN (1) | CN1165000A (pt) |
| AT (1) | ATE216226T1 (pt) |
| AU (1) | AU714038B2 (pt) |
| CA (1) | CA2198536C (pt) |
| DE (1) | DE69711965T2 (pt) |
| DK (1) | DK0791355T3 (pt) |
| ES (1) | ES2174176T3 (pt) |
| IL (1) | IL120271A (pt) |
| MY (1) | MY118982A (pt) |
| PT (1) | PT791355E (pt) |
| ZA (1) | ZA971715B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ514144A (en) * | 1999-04-01 | 2001-09-28 | Pfizer Prod Inc | Aminopyrimidines as sorbitol dehydrogenase inhibitors |
| US6825198B2 (en) * | 2001-06-21 | 2004-11-30 | Pfizer Inc | 5-HT receptor ligands and uses thereof |
| CN104346404B (zh) * | 2013-08-08 | 2018-05-18 | 华为技术有限公司 | 一种访问数据的方法、设备及系统 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3905364A1 (de) | 1989-02-22 | 1990-08-23 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool |
| DE4025387A1 (de) | 1990-08-10 | 1992-02-13 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als reagenzien |
| EP0662962A1 (en) | 1992-09-28 | 1995-07-19 | Pfizer Inc. | Substituted pyrimidines for control of diabetic complications |
-
1997
- 1997-02-13 PT PT97200415T patent/PT791355E/pt unknown
- 1997-02-13 DE DE69711965T patent/DE69711965T2/de not_active Expired - Fee Related
- 1997-02-13 ES ES97200415T patent/ES2174176T3/es not_active Expired - Lifetime
- 1997-02-13 DK DK97200415T patent/DK0791355T3/da active
- 1997-02-13 EP EP97200415A patent/EP0791355B1/en not_active Expired - Lifetime
- 1997-02-13 AT AT97200415T patent/ATE216226T1/de not_active IP Right Cessation
- 1997-02-20 US US08/803,302 patent/US5932581A/en not_active Expired - Fee Related
- 1997-02-20 IL IL12027197A patent/IL120271A/en not_active IP Right Cessation
- 1997-02-25 JP JP9040466A patent/JPH09316004A/ja active Pending
- 1997-02-26 CA CA002198536A patent/CA2198536C/en not_active Expired - Fee Related
- 1997-02-27 KR KR1019970006295A patent/KR100219972B1/ko not_active IP Right Cessation
- 1997-02-27 MY MYPI97000795A patent/MY118982A/en unknown
- 1997-02-27 ZA ZA971715A patent/ZA971715B/xx unknown
- 1997-02-28 AU AU15009/97A patent/AU714038B2/en not_active Ceased
- 1997-02-28 CN CN97103411A patent/CN1165000A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MY118982A (en) | 2005-02-28 |
| ZA971715B (en) | 1998-08-27 |
| MX9701527A (es) | 1998-06-30 |
| EP0791355A1 (en) | 1997-08-27 |
| IL120271A (en) | 2001-06-14 |
| DE69711965D1 (de) | 2002-05-23 |
| IL120271A0 (en) | 1997-06-10 |
| EP0791355B1 (en) | 2002-04-17 |
| AU1500997A (en) | 1997-09-04 |
| ES2174176T3 (es) | 2002-11-01 |
| KR100219972B1 (ko) | 1999-09-01 |
| CN1165000A (zh) | 1997-11-19 |
| CA2198536C (en) | 2000-06-20 |
| ATE216226T1 (de) | 2002-05-15 |
| JPH09316004A (ja) | 1997-12-09 |
| US5932581A (en) | 1999-08-03 |
| DK0791355T3 (da) | 2002-06-17 |
| KR970061257A (ko) | 1997-09-12 |
| CA2198536A1 (en) | 1997-08-29 |
| AU714038B2 (en) | 1999-12-16 |
| DE69711965T2 (de) | 2003-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT811352E (pt) | Instrumento oftalmologico para a determinacao da topografia da cornea | |
| DE69709707T2 (de) | Gewebebehandlungsmittel mit kontrollierter freisetzung | |
| NZ501069A (en) | Monoesters of probucol for the treatment of cardiovascular and inflammatory disease | |
| ES2172748T3 (es) | Uso de un inhibidor de aldosa reductasa para la reduccion de daño en tejido no cardiaco. | |
| BR9202740A (pt) | Composicao para o cudado de tecidos | |
| DE69821731D1 (de) | Augenbandage zum Gebrauch nach intraokularen Operationen | |
| AU4008597A (en) | The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives | |
| DK0764157T3 (da) | Benzopyraner og deres anvendelse som terapeutiske midler | |
| PT791355E (pt) | Metodo para diminuir os daos associados com a isquemia nos tecidos | |
| NO20004920D0 (no) | Anvendelse av proteaseinhibitorer for behandling av hudskader | |
| DE69100171D1 (de) | Synergistische kombination zur ophthalmischen verwendung. | |
| AU2003252178A1 (en) | Use of 2,3 alkylcarbonyloxybenzoic acids, derivatives and analogues therefrom in the treatment of tissue and cellular dysfunction damage and injury in mammals | |
| AR004330A1 (es) | Uso de inhibidores de colinesterasa en el tratamiento de xerostomia | |
| DK0711163T3 (da) | Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF | |
| KR940020354U (ko) | 당구큐우의 팁 연마기 | |
| KR950022756U (ko) | 휴대용 구두닦이 티슈 | |
| SI0898562T1 (en) | Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation | |
| ITUD940156A0 (it) | Procedimento di perfezionamento dell'operazione di garzatura di tessuti e dispositivo relativo | |
| ECSP941161A (es) | Tractor cutaneo para tratamiento de quemados y cirugia plastica en general | |
| IT236181Y1 (it) | Punta perfezionata per chirurgia oculistica,in particolare per larimozione della cataratta | |
| BR9302334A (pt) | Urovarginal para pacientes | |
| KR950010452U (ko) | 볼링장용 오토 스코아링 모니터 | |
| LV11274A (lv) | Audu defektu korekcijas sastavs | |
| ES1031273Y (es) | Protector desechable para talones y codos en pacientes encamados. | |
| ATA169694A (de) | Kegelbahn |